Primary Skull Base Lymphoma: Manifestations and Clinical Outcomes of a Great Imitator

Otolaryngol Head Neck Surg. 2018 Oct;159(4):643-649. doi: 10.1177/0194599818773994. Epub 2018 May 8.

Abstract

Objectives Primary skull base lymphoma (PSBL) represents a rare manifestation of extranodal lymphoma. Presenting with nonspecific symptomatology and imaging findings, PSBL often masquerades as more common cranial base pathology and thus can present a diagnostic challenge. The objectives of this study were to characterize the manifestations and clinical outcomes of PSBL. Study Design Case series and chart review. Setting Tertiary referral center. Subjects and Methods Review of 48 patients with PSBL treated between 1994 and 2016. Results The median age at diagnosis was 60 years. Diffuse large B-cell lymphoma comprised the most common subtype (56%). Presenting symptoms included diplopia (52%), trigeminal hypesthesia (38%), headache (29%), facial nerve weakness (25%), B-symptoms (fevers, night sweats, and/or weight loss) (25%), and hearing loss (21%). Discrete lesions commonly mimicked meningioma, schwannoma, and nasopharyngeal carcinoma. Diffuse lesions imitated neurosarcoidosis, granulomatosis with polyangiitis, and carcinomatosis meningitis. Only 26% of all initial clinical evaluations suspected lymphoma. The combination of restricted diffusion on diffusion-weighted imaging, an absence of flow voids or surrounding hyperostosis, bony erosion and/or marrow signal replacement, and heterogeneous contrast enhancement facilitated delineation between PSBL and common skull base pathology. Cerebrospinal fluid (CSF) analysis was diagnostic of lymphoma in 24% of cases. Lymphoma within CSF portended significantly worse overall survival (85% vs 18% at 3-years; P < .001). Conclusion A history significant for multiple cranial nerve palsies, B-symptoms, and imaging findings inconsistent with common skull base pathology should raise suspicion for PSBL. CSF analysis in the setting of PSBL can provide diagnostic and prognostic value for patients.

Keywords: cranial base; diffuse large B-cell lymphoma; esthesioneuroblastoma; lymphoma; meningioma; nasopharyngeal carcinoma; neurosarcoidosis; schwannoma; skull base; survival.

MeSH terms

  • Adult
  • Aged
  • Biopsy, Needle
  • Central Nervous System Diseases / diagnostic imaging
  • Central Nervous System Diseases / pathology
  • Central Nervous System Diseases / therapy
  • Chemoradiotherapy / methods
  • Cohort Studies
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Lymphoma / diagnostic imaging
  • Lymphoma / mortality
  • Lymphoma / pathology*
  • Lymphoma / therapy*
  • Lymphoma, Large B-Cell, Diffuse / diagnostic imaging
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Magnetic Resonance Imaging / methods
  • Male
  • Meningioma / diagnostic imaging
  • Meningioma / pathology
  • Meningioma / therapy
  • Middle Aged
  • Neurilemmoma / diagnostic imaging
  • Neurilemmoma / pathology
  • Neurilemmoma / therapy
  • Rare Diseases
  • Retrospective Studies
  • Sarcoidosis / diagnostic imaging
  • Sarcoidosis / pathology
  • Sarcoidosis / therapy
  • Skull Base Neoplasms / diagnostic imaging
  • Skull Base Neoplasms / mortality
  • Skull Base Neoplasms / pathology*
  • Skull Base Neoplasms / therapy*
  • Statistics, Nonparametric
  • Survival Analysis

Supplementary concepts

  • Neurosarcoidosis